Oberweis Asset Management Inc Castle Biosciences Inc Transaction History

Oberweis Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $871,044 - $1.23 Million	-26,260 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $2.87 Million - $3.71 Million	-47,800 Reduced 64.54%	26,260 $1.75 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $1.15 Million - $1.77 Million	-23,010 Reduced 23.7%	74,060 $5.43 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $3.89 Million - $6.43 Million	-66,040 Reduced 40.49%	97,070 $6.65 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $104,204 - $174,589	2,390 Added 1.49%	163,110 $11 Million

Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $66,553 - $90,011	1,730 Added 1.09%	160,720 $8.27 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $1.94 Million - $3.06 Million	71,180 Added 81.06%	158,990 $5.99 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $844,958 - $1.3 Million	36,610 Added 71.5%	87,810 $2.62 Million
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $805,888 - $1.79 Million	51,200 New	51,200 $1.76 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.